Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for kids with tough leukemia: first thai trial of modified immune cell therapy

NCT ID NCT07078929

Summary

This is a first-in-Thailand study testing a new type of CAR-T cell therapy (called CMD63) in children whose B-cell leukemia has come back or hasn't responded to standard treatments. Doctors take a child's own immune cells, modify them in a lab to better target and fight leukemia cells, and then infuse them back. The main goal of this early-phase trial is to check if the treatment is safe and to see initial signs of whether it helps control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSE B ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • King Chulalongkorn Memorial Hospital

    RECRUITING

    Bangkok, Pathumwan, 10330, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • Maharaj Nakorn Chiang Mai Hospital

    NOT_YET_RECRUITING

    Chiang Mai, Mueang Chiang Mai District, 50200, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Siriraj Hospital

    NOT_YET_RECRUITING

    Bangkok, Bangkoknoi, 10700, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.